Palladiem’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.53K Hold
19
﹤0.01% 127
2025
Q4
$3.93K Buy
+19
New +$3.76K ﹤0.01% 137
2022
Q1
Sell
-1,589
Closed -$272K 67
2021
Q4
$272K Buy
1,589
+1
+0.1% +$164 0.22% 46
2021
Q3
$256K Hold
1,588
0.21% 43
2021
Q2
$262K Hold
1,588
0.21% 50
2021
Q1
$261K Hold
1,588
0.23% 44
2020
Q4
$250K Buy
+1,588
New +$234K 0.23% 50
2015
Q3
$75K Hold
805
0.12% 43
2015
Q2
$78K Sell
805
-400
-33% -$40.1K 0.06% 46
2015
Q1
$121K Sell
1,205
-135
-10% -$13.7K 0.1% 32
2014
Q4
$140K Buy
+1,340
New +$141K 0.11% 36

Other funds holding JNJ

Palladiem's JNJ Position: Q1 2026 in Review

Palladiem held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 19 shares worth $4.53K. The position accounts for ﹤0.01% of the portfolio, ranked #127.

Palladiem first reported a position in JNJ in Q4 2014 and has held it in 11 quarters since. The position peaked at $272K in Q4 2021. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Palladiem held 19 shares of Johnson & Johnson worth $4.53K as of Q1 2026.
  • Palladiem left its Johnson & Johnson share count unchanged in Q1 2026.
  • Johnson & Johnson made up ﹤0.01% of Palladiem's portfolio in Q1 2026, its #127 holding.
  • Palladiem first reported a position in Johnson & Johnson in Q4 2014 and has held it in 11 quarters since.
  • Palladiem's Johnson & Johnson position peaked at $272K in Q4 2021.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Palladiem's 13F filing for Q1 2026, filed 6 May 2026.